Showing results (201-210 of 214) with videos related to

Sort By:
Pageof 22
Blood|February 1, 1995
Molecular characterization of 16p deletions associated with inversion 16 defines the critical fusion for leukemogenesisP Marlton, D F Claxton, P Liu, et al.
Leukemia|May 1, 1987
The localization of the human myeloperoxidase gene is in close proximity to the translocation breakpoint in acute promyelocytic leukemiaK S Chang, W Schroeder, M J Siciliano, et al.
Blood|December 3, 1998
Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor is toxic to blasts from patients with juvenile myelomonocytic leukemia and chronic myelomonocytic leukemiaA E Frankel, M Lilly, R Kreitman, et al.
Blood|February 15, 1992
Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA)E H Estey, R Kurzrock, H M Kantarjian, et al.
Cancer|November 1, 1986
Clinical and prognostic features of Philadelphia chromosome-negative chronic myelogenous leukemiaH M Kantarjian, M J Keating, R S Walters, et al.
Leukemia|February 27, 2009
Phase II study of rabbit anti-thymocyte globulin, cyclosporine and granulocyte colony-stimulating factor in patients with aplastic anemia and myelodysplastic syndromeR Garg, S Faderl, G Garcia-Manero, et al.
Cancer Treatment Reports|February 1, 1982
High-dose AMSA and bone marrow rescue in patients with solid tumorsA R Zander, G Spitzer, S Legha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Treatment of Philadelphia chromosome-positive early chronic phase chronic myelogenous leukemia with daily doses of interferon alpha and low-dose cytarabineH M Kantarjian, S O'Brien, T L Smith, et al.
Leukemia|April 14, 2000
Diphtheria toxin fused to human interleukin-3 is toxic to blasts from patients with myeloid leukemiasA E Frankel, J A McCubrey, M S Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Topotecan and cytarabine is an active combination regimen in myelodysplastic syndromes and chronic myelomonocytic leukemiaM Beran, E Estey, S O'Brien, et al.
Pageof 22